Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial

G. Illerhaus; K. Cwynarski; E. Pulczynski; M. Ponzoni; M. Deckert; L. S. Politi; C. P. Fox; P. La Rose; A. Ambrosetti; A. Roeth; A. Hemmaway; F. Ilariucci; K. M. Linton; R. Soffietti; T. Pukrop; M. Binder; M. Balzarotti; A. Fabbri; P. Johnson; J. S. Gorlov; F. Cavalli; J. Finke; E. Schorb; M. Reni; E. Zucca; A. J. M. Ferrer

Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial

G. Illerhaus, K. Cwynarski, E. Pulczynski, M. Ponzoni, M. Deckert, L. S. Politi, C. P. Fox, P. La Rose, A. Ambrosetti, A. Roeth, A. Hemmaway, F. Ilariucci, K. M. Linton, R. Soffietti, T. Pukrop, M. Binder, M. Balzarotti, A. Fabbri, P. Johnson, J. S. GorlovF. Cavalli, J. Finke, E. Schorb, M. Reni, E. Zucca, A. J. M. Ferrer

Department of Materials

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Journal	Oncology Research and Treatment
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Illerhaus, G., Cwynarski, K., Pulczynski, E., Ponzoni, M., Deckert, M., Politi, L. S., Fox, C. P., La Rose, P., Ambrosetti, A., Roeth, A., Hemmaway, A., Ilariucci, F., Linton, K. M., Soffietti, R., Pukrop, T., Binder, M., Balzarotti, M., Fabbri, A., Johnson, P., ... Ferrer, A. J. M. (2015). Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial. Oncology Research and Treatment.

@article{9fc3a5f058244bddbcf760193e74ffa5,

title = "Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial",

author = "G. Illerhaus and K. Cwynarski and E. Pulczynski and M. Ponzoni and M. Deckert and Politi, {L. S.} and Fox, {C. P.} and {La Rose}, P. and A. Ambrosetti and A. Roeth and A. Hemmaway and F. Ilariucci and Linton, {K. M.} and R. Soffietti and T. Pukrop and M. Binder and M. Balzarotti and A. Fabbri and P. Johnson and Gorlov, {J. S.} and F. Cavalli and J. Finke and E. Schorb and M. Reni and E. Zucca and Ferrer, {A. J. M.}",

year = "2015",

language = "Undefined",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "S. Karger AG",

}

Illerhaus, G, Cwynarski, K, Pulczynski, E, Ponzoni, M, Deckert, M, Politi, LS, Fox, CP, La Rose, P, Ambrosetti, A, Roeth, A, Hemmaway, A, Ilariucci, F, Linton, KM, Soffietti, R, Pukrop, T, Binder, M, Balzarotti, M, Fabbri, A, Johnson, P, Gorlov, JS, Cavalli, F, Finke, J, Schorb, E, Reni, M, Zucca, E & Ferrer, AJM 2015, 'Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial', Oncology Research and Treatment.

TY - JOUR

T1 - Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma

T2 - Results of the first randomization of the IELSG-32 trial

AU - Illerhaus, G.

AU - Cwynarski, K.

AU - Pulczynski, E.

AU - Ponzoni, M.

AU - Deckert, M.

AU - Politi, L. S.

AU - Fox, C. P.

AU - La Rose, P.

AU - Ambrosetti, A.

AU - Roeth, A.

AU - Hemmaway, A.

AU - Ilariucci, F.

AU - Linton, K. M.

AU - Soffietti, R.

AU - Pukrop, T.

AU - Binder, M.

AU - Balzarotti, M.

AU - Fabbri, A.

AU - Johnson, P.

AU - Gorlov, J. S.

AU - Cavalli, F.

AU - Finke, J.

AU - Schorb, E.

AU - Reni, M.

AU - Zucca, E.

AU - Ferrer, A. J. M.

PY - 2015

Y1 - 2015

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000364268800426&KeyUID=WOS:000364268800426

M3 - Article

SN - 2296-5270

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

ER -

Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial

UN SDGs

Other files and links

Cite this